HCPlive (11/26, Derman) reports, “A new study indicated high-dose antipsychotic use for schizophrenia was associated with increased mortality risk.” Investigators came to this conclusion after analyzing data on “32,240 patients aged 17 – 64 years…diagnosed with schizophrenia between January 1, 2002, and December 31, 2012.” The findings were published in JAMA Network Open.

Related Links:

— “Can Antipsychotics Increase Mortality Risk? A New Study Shows It Might,” Chelsie Derman, HCPLive, November 26, 2024

The New York Times (11/25, Lewis) reports that following an incident last January on an Alaska Airlines flight in which “one of the plane’s doors had blown off,” over “30 other passengers from the Alaska Airlines flight are suing the carrier and Boeing, the aircraft manufacturer, citing ‘severe stress, anxiety, trauma, physical pain, flashbacks and fear of flying and also objective physical manifestations such as sleeplessness, PTSD, hearing damage and other injuries.’”

Such “harm inflicted on passengers who experienced in-flight emergencies…ha s not been as researched or recognized.” The Times adds, “Neither the Federal Aviation Administration nor the National Transportation Safety Board has policies or recommendations regarding passenger mental health after emergencies.”

Related Links:

— “The New York Times (requires login and subscription)

MedPage Today (11/25, DePeau-Wilson ) reports, “Lack of control over their work environment fostered burnout among physicians, along with an increased desire to bail out of the organization, according to a multi-institutio nal study.” An “analysis of data from 2,339 physicians revealed that those who reported having poor control over their workload had higher levels of burnout (OR 3.83, 95% CI 2.99-4.90),” according to investigators. The findings were published in Annals of Internal Medicine.

Related Links:

— MedPage Today (requires login and subscription)

Psychiatric News (11/22) reported, “Short-term menopausal hormone therapy does not appear to have any long-term cognitive effects, either positive or negative, according to a study.” The researchers said the findings “may reassure women opting to use hormone therapy in early menopause, to manage menopausal symptoms, that 4 years of therapy started within 3 years of menopause had no long-term deleterious impact on cognition.” The findings were published in PLOS Medicine.

Related Links:

— “Short-Term Menopausal Hormone Therapy Does Not Affect Long-Term Cognition, Study Finds,” Psychiatric News , November 22, 2024

The New York Times (11/22, Schmall ) reported, “A company that makes clonazepam, a drug commonly prescribed for anxiety and seizures, has expanded its recall of some of the pills after it discovered that they were labeled with the wrong strength, the Food and Drug Administration announced.” According to the Times, “the company, Endo, recalled 16 product lots of clonazepam, a drug best known by the brand name Klonopin.” Endo “said it had not received any reports of adverse events related to the recall.”

Related Links: — “The New York Times (requires login and subscription)